<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-128439</identifier>
<setSpec>1887-8571</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Positive assessment of drugs: March, April and May 2014</dc:title>
<dc:description xml:lang="en">The drugs assessed by the Spanish Agency for Medicines and Health Products made public in April, May and June of 2014, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product (AU) </dc:description>
<dc:creator>García Luque, A</dc:creator>
<dc:creator>Sanchez López, P</dc:creator>
<dc:creator>Tabakov, A</dc:creator>
<dc:creator>Cabanes Mariscal, M. A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Se reseñan los medicamentos ya evaluados por la Agencia Española de Medicamentos y Productos Sanitarios hechos públicos en abril, mayo y junio de 2014, y considerados de mayor interés para el profesional sanitario. Se trata de opiniones técnicas positivas que son previas a la autorización y puesta en el mercado del medicamento (AU)</dc:description>
<dc:source>Sanid. mil;70(3): 191-196, jul.-sept. 2014.</dc:source>
<dc:identifier>ibc-128439</dc:identifier>
<dc:title xml:lang="es">Evaluación positiva de medicamentos: marzo, abril y mayo 2014</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d30745</dc:subject>
<dc:subject>^d4401</dc:subject>
<dc:subject>^d4403</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30681</dc:subject>
<dc:type>article</dc:type>
<dc:date>201409</dc:date>
</metadata>
</record>
</ibecs-document>
